High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso

Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso. During 2 months (June-July 2014),...

Full description

Saved in:
Bibliographic Details
Published inBMC infectious diseases Vol. 16; no. 1; p. 326
Main Authors Ouedraogo, Abdoul-Salam, Sanou, Mahamadou, Kissou, Aimée, Sanou, Soufiane, Solaré, Hermann, Kaboré, Firmin, Poda, Armel, Aberkane, Salim, Bouzinbi, Nicolas, Sano, Idrissa, Nacro, Boubacar, Sangaré, Lassana, Carrière, Christian, Decré, Dominique, Ouégraogo, Rasmata, Jean-Pierre, Hélène, Godreuil, Sylvain
Format Journal Article
LanguageEnglish
Published England BioMed Central 11.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso. During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method. ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected. This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination.
AbstractList Background Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso. Methods During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Muller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method. Results ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected. Conclusions This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination.
Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso.BACKGROUNDNothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso.During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method.METHODSDuring 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method.ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected.RESULTSESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected.This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination.CONCLUSIONSThis report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination.
Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso. During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method. ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected. This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination.
BACKGROUND:Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso.METHODS:During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method.RESULTS:ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected.CONCLUSIONS:This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination.
ArticleNumber 326
Author Poda, Armel
Bouzinbi, Nicolas
Ouedraogo, Abdoul-Salam
Kaboré, Firmin
Sanou, Soufiane
Godreuil, Sylvain
Kissou, Aimée
Aberkane, Salim
Decré, Dominique
Nacro, Boubacar
Sanou, Mahamadou
Carrière, Christian
Solaré, Hermann
Sangaré, Lassana
Ouégraogo, Rasmata
Sano, Idrissa
Jean-Pierre, Hélène
Author_xml – sequence: 1
  givenname: Abdoul-Salam
  surname: Ouedraogo
  fullname: Ouedraogo, Abdoul-Salam
– sequence: 2
  givenname: Mahamadou
  surname: Sanou
  fullname: Sanou, Mahamadou
– sequence: 3
  givenname: Aimée
  surname: Kissou
  fullname: Kissou, Aimée
– sequence: 4
  givenname: Soufiane
  surname: Sanou
  fullname: Sanou, Soufiane
– sequence: 5
  givenname: Hermann
  surname: Solaré
  fullname: Solaré, Hermann
– sequence: 6
  givenname: Firmin
  surname: Kaboré
  fullname: Kaboré, Firmin
– sequence: 7
  givenname: Armel
  surname: Poda
  fullname: Poda, Armel
– sequence: 8
  givenname: Salim
  surname: Aberkane
  fullname: Aberkane, Salim
– sequence: 9
  givenname: Nicolas
  surname: Bouzinbi
  fullname: Bouzinbi, Nicolas
– sequence: 10
  givenname: Idrissa
  surname: Sano
  fullname: Sano, Idrissa
– sequence: 11
  givenname: Boubacar
  surname: Nacro
  fullname: Nacro, Boubacar
– sequence: 12
  givenname: Lassana
  surname: Sangaré
  fullname: Sangaré, Lassana
– sequence: 13
  givenname: Christian
  surname: Carrière
  fullname: Carrière, Christian
– sequence: 14
  givenname: Dominique
  surname: Decré
  fullname: Decré, Dominique
– sequence: 15
  givenname: Rasmata
  surname: Ouégraogo
  fullname: Ouégraogo, Rasmata
– sequence: 16
  givenname: Hélène
  surname: Jean-Pierre
  fullname: Jean-Pierre, Hélène
– sequence: 17
  givenname: Sylvain
  surname: Godreuil
  fullname: Godreuil, Sylvain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27400864$$D View this record in MEDLINE/PubMed
https://hal.science/hal-01862672$$DView record in HAL
BookMark eNp1ks1u1DAUhSNURH_gAdggS2xgEfBPYicbpFJRBmkkNrC2buybGZfEHuxkBE_Th-mL4WhaVEZiZcv3O-dc2_e8OPHBY1G8ZPQdY418nxhvVFtSJksm67oUT4ozVilWciGqk0f70-I8pRtKmWp4-6w45aqitJHVWbFfuc2W7CLuYUBvkISe4K8JvUVbph2aKc4jubstBzATjJAww8HOxvkNQT9hDF2uYHRgEJDAGHLBDM47AwNxKQwwYSLOk49z_OE8kGtI4XnxtIch4Yv79aL4fv3p29WqXH_9_OXqcl0aoaQoawa2Rd4p25m-RcpN3YmGS8pAmcpa3tW27m3XgmEVraw0nQRbyV7xvqFWiYviw8F3N3cjWpM7jjDoXXQjxN86gNP_Vrzb6k3Y66oVbd0sBm8PBtsj2epyrZczmj-CS8X3LLNv7sNi-DljmvToksFhAI9hTpo1VKhWtdWCvj5Cb8IcfX6KhVJNjmZL-KvH3f_Nf_i-DKgDYGJIKWKvjZtgcmG5jBs0o3oZFH0YlNyr1MugaJGV7Ej5YP5_zR9Q9cK7
CitedBy_id crossref_primary_10_2147_IDR_S349566
crossref_primary_10_1016_j_medmal_2018_07_007
crossref_primary_10_3390_app13010442
crossref_primary_10_3390_genes15080985
crossref_primary_10_1155_2022_5727638
crossref_primary_10_1186_s13756_021_00941_8
crossref_primary_10_5897_AJPP2021_5290
crossref_primary_10_2147_IDR_S363988
crossref_primary_10_2147_IDR_S358116
crossref_primary_10_5897_AJMR2021_9489
crossref_primary_10_1111_tmi_13644
crossref_primary_10_3389_fmicb_2020_567235
crossref_primary_10_3390_antibiotics13010093
crossref_primary_10_3389_fmicb_2017_01904
crossref_primary_10_3390_antibiotics10070835
crossref_primary_10_1089_mdr_2018_0314
crossref_primary_10_30699_ijmm_16_6_490
crossref_primary_10_1186_s42522_023_00081_6
crossref_primary_10_4236_jbm_2025_131030
crossref_primary_10_3390_microbiolres15040153
crossref_primary_10_1186_s12887_019_1709_y
crossref_primary_10_1089_sur_2023_375
crossref_primary_10_1016_j_ijantimicag_2020_106203
crossref_primary_10_1007_s13353_022_00718_8
crossref_primary_10_3390_tropicalmed6040179
crossref_primary_10_3389_fcimb_2023_1322874
crossref_primary_10_1371_journal_pone_0172652
crossref_primary_10_14202_IJOH_2024_12_19
crossref_primary_10_61186_JoMMID_11_2_110
crossref_primary_10_5897_AJMR2017_8778
crossref_primary_10_5897_AJMR2017_8535
crossref_primary_10_1186_s12879_023_08742_7
crossref_primary_10_1371_journal_pone_0222911
crossref_primary_10_1016_j_jgar_2020_04_010
crossref_primary_10_1186_s13756_023_01220_4
crossref_primary_10_1371_journal_pone_0268991
crossref_primary_10_3390_medsci7110104
crossref_primary_10_4103_jdrntruhs_jdrntruhs_105_21
crossref_primary_10_2147_IDR_S485200
crossref_primary_10_3390_tropicalmed4030117
crossref_primary_10_1186_s40001_024_02267_8
crossref_primary_10_2147_IDR_S269425
crossref_primary_10_1007_s10096_023_04629_2
crossref_primary_10_5812_iji_83194
crossref_primary_10_1089_mdr_2020_0497
crossref_primary_10_3389_fcimb_2022_955774
crossref_primary_10_2174_2211352519666210422131526
crossref_primary_10_1186_s13756_019_0488_4
crossref_primary_10_1186_s13756_020_00856_w
crossref_primary_10_1155_2020_6679029
crossref_primary_10_3390_antibiotics13111059
crossref_primary_10_1007_s00003_024_01493_w
crossref_primary_10_1016_j_heliyon_2020_e03206
crossref_primary_10_1080_14789450_2017_1260451
crossref_primary_10_1111_tmi_13868
crossref_primary_10_3390_antibiotics12010148
crossref_primary_10_33393_dti_2023_2613
crossref_primary_10_1016_j_sciaf_2022_e01106
crossref_primary_10_4236_ojmm_2023_131004
crossref_primary_10_37376_ljst_v14i1_7170
crossref_primary_10_1186_s12879_019_3838_1
crossref_primary_10_14202_IJOH_2022_124_160
crossref_primary_10_5897_AJMR2017_8598
crossref_primary_10_7759_cureus_40183
crossref_primary_10_1099_acmi_0_000195
crossref_primary_10_1186_s12866_024_03485_0
crossref_primary_10_3390_antibiotics12061016
crossref_primary_10_1371_journal_pone_0274156
crossref_primary_10_1155_2024_7463899
crossref_primary_10_1186_s12887_020_02342_z
crossref_primary_10_2147_IDR_S442646
crossref_primary_10_1186_s13104_018_3581_5
Cites_doi 10.1111/j.1469-0691.2008.02074.x
10.1128/AAC.00675-09
10.1111/1758-2229.12019
10.1086/500936
10.1093/jac/dkp498
10.1007/s10096-014-2141-8
10.1128/JCM.43.7.3309-3313.2005
10.1016/j.diagmicrobio.2010.11.011
10.1111/j.1469-0691.2007.01867.x
10.1093/clinids/10.4.867
10.1186/1471-2180-12-155
10.1007/s10096-003-1084-2
10.1128/CMR.18.4.657-686.2005
10.1007/s10096-008-0656-6
10.3201/eid1402.070350
10.2147/IDR.S74934
10.1186/1471-2334-10-204
10.1016/j.medmal.2015.08.003
10.1080/21548331.2016.1133214
10.2807/ese.13.47.19044-en
10.1089/mdr.2009.0108
10.1016/j.mib.2006.08.011
10.1093/jac/dkm144
10.17305/bjbms.2011.2588
10.1186/1476-0711-12-16
10.1111/j.1469-0691.2007.01866.x
10.1046/j.1469-0691.2000.00002.x
10.1089/mdr.1999.5.189
10.1093/jac/dkl199
10.3402/iee.v4.20342
10.1093/jac/dkp194
10.1038/ja.2012.91
10.1093/jac/dkm381
10.4269/ajtmh.12-0642
10.1016/j.urology.2013.02.040
10.1016/j.ajic.2005.03.009
10.1186/2047-2994-1-23
10.1111/j.1469-0691.2007.01850.x
10.1155/2015/846219
10.1016/j.ijantimicag.2006.01.007
10.1007/s10096-012-1717-4
ContentType Journal Article
Copyright Copyright BioMed Central 2016
Attribution
The Author(s). 2016
Copyright_xml – notice: Copyright BioMed Central 2016
– notice: Attribution
– notice: The Author(s). 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7T2
7U9
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
1XC
VOOES
5PM
DOI 10.1186/s12879-016-1655-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2334
ExternalDocumentID PMC4939587
oai_HAL_hal_01862672v1
4133661141
27400864
10_1186_s12879_016_1655_3
Genre Journal Article
GroupedDBID ---
0R~
23N
2WC
4.4
53G
5VS
6J9
6PF
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
IOV
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
1XC
VOOES
5PM
ID FETCH-LOGICAL-c3763-51ad9e2b7dbcf9e02c5b382601a7c4dd2b5d5fdb9ac1404d6cb6ad46f72f80d73
IEDL.DBID M48
ISSN 1471-2334
IngestDate Thu Aug 21 17:45:49 EDT 2025
Thu Aug 14 06:50:33 EDT 2025
Fri Jul 11 07:22:30 EDT 2025
Fri Jul 25 07:02:44 EDT 2025
Thu Jan 02 23:11:54 EST 2025
Thu Apr 24 23:03:39 EDT 2025
Tue Jul 01 01:57:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords ESBL
Burkina Faso
Clinical samples
Inpatient and outpatient
Enterobacteriaceae
Language English
License Attribution: http://creativecommons.org/licenses/by
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3763-51ad9e2b7dbcf9e02c5b382601a7c4dd2b5d5fdb9ac1404d6cb6ad46f72f80d73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC4939587
ORCID 0000-0002-8539-3768
0000-0003-3436-0082
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12879-016-1655-3
PMID 27400864
PQID 1807858717
PQPubID 42582
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4939587
hal_primary_oai_HAL_hal_01862672v1
proquest_miscellaneous_1803797941
proquest_journals_1807858717
pubmed_primary_27400864
crossref_citationtrail_10_1186_s12879_016_1655_3
crossref_primary_10_1186_s12879_016_1655_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-07-11
PublicationDateYYYYMMDD 2016-07-11
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-07-11
  day: 11
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC infectious diseases
PublicationTitleAlternate BMC Infect Dis
PublicationYear 2016
Publisher BioMed Central
Publisher_xml – name: BioMed Central
References 1655_CR17
1655_CR39
1655_CR14
D Iranpour (1655_CR46) 2015; 2015
1655_CR15
1655_CR12
1655_CR13
DL Paterson (1655_CR6) 2005; 18
1655_CR32
1655_CR11
1655_CR33
H Zhang (1655_CR36) 2015; 6
1655_CR30
J Rodriguez-Bano (1655_CR25) 2008; 14
GM Rossolini (1655_CR5) 2008; 14
J Gangoue-Pieboji (1655_CR29) 2006; 6
R Colodner (1655_CR3) 2004; 23
R Ben-Ami (1655_CR28) 2006; 42
N Obeng-Nkrumah (1655_CR7) 2013; 89
C Dallenne (1655_CR9) 2010; 65
RA Afunwa (1655_CR24) 2011; 11
G Peirano (1655_CR34) 2011; 69
1655_CR18
S Dahmen (1655_CR40) 2010; 16
1655_CR19
1655_CR27
J Silva (1655_CR35) 1999; 5
ZA Kanafani (1655_CR16) 2005; 33
O Clermont (1655_CR10) 2013; 5
1655_CR23
1655_CR45
V Jarlier (1655_CR8) 1988; 10
1655_CR43
MH Mohamed Al-Agamy (1655_CR38) 2006; 27
1655_CR44
JJ Rahal (1655_CR1) 2000; 6
R Raz (1655_CR26) 2000; 2
R Canton (1655_CR4) 2006; 9
1655_CR42
T Nakayama (1655_CR22) 2015; 8
EA Newire (1655_CR2) 2013; 12
MM Oh (1655_CR21) 2013; 81
CM Lonchel (1655_CR41) 2013; 32
J Kiiru (1655_CR37) 2012; 12
T Hara (1655_CR31) 2015; 68
M Kumar (1655_CR20) 2015; 9
26433872 - Med Mal Infect. 2015 Sep;45(9):374-82
3263690 - Rev Infect Dis. 1988 Jul-Aug;10(4):867-78
19721071 - Antimicrob Agents Chemother. 2009 Nov;53(11):4957-8
24043693 - Am J Trop Med Hyg. 2013 Nov;89(5):960-4
16717055 - J Antimicrob Chemother. 2006 Jul;58(1):205-10
22958481 - Antimicrob Resist Infect Control. 2012 Jun 06;1(1):23
18154526 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:33-41
26673518 - Hosp Pract (1995). 2016;44(1):33-40
10566868 - Microb Drug Resist. 1999 Fall;5(3):189-93
25870591 - Front Microbiol. 2015 Mar 27;6:239
16511754 - Clin Infect Dis. 2006 Apr 1;42(7):925-34
16223952 - Clin Microbiol Rev. 2005 Oct;18(4):657-86
25670909 - Infect Drug Resist. 2015 Jan 23;8:1-5
18154538 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53
20071363 - J Antimicrob Chemother. 2010 Mar;65(3):490-5
14986159 - Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):163-7
20624313 - BMC Infect Dis. 2010 Jul 12;10:204
16942899 - Curr Opin Microbiol. 2006 Oct;9(5):466-75
23601450 - Urology. 2013 Jun;81(6):1209-12
18154533 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:104-10
16061138 - Am J Infect Control. 2005 Aug;33(6):326-32
19021958 - Euro Surveill. 2008 Nov 20;13(47):null
18828851 - Clin Microbiol Infect. 2008 Oct;14(10):895-907
24807441 - Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1719-23
18258110 - Emerg Infect Dis. 2008 Feb;14(2):195-200
19474064 - J Antimicrob Chemother. 2009 Aug;64(2):274-7
16713187 - Int J Antimicrob Agents. 2006 Jun;27(6):545-8
23757131 - Environ Microbiol Rep. 2013 Feb;5(1):58-65
11523521 - Clin Microbiol Infect. 2000 Aug;6 Suppl 2:2-6
24765249 - Infect Ecol Epidemiol. 2014 Mar 13;4:null
16000453 - J Clin Microbiol. 2005 Jul;43(7):3309-13
22838634 - BMC Microbiol. 2012 Jul 28;12:155
26182812 - Jpn J Antibiot. 2015 Apr;68(2):75-84
20438347 - Microb Drug Resist. 2010 Jun;16(2):163-70
17604512 - Afr Health Sci. 2006 Dec;6(4):232-5
17496058 - J Antimicrob Chemother. 2007 Jul;60(1):140-4
25692147 - Biomed Res Int. 2015;2015:846219
10897231 - Isr Med Assoc J. 2000 Jun;2(6):426-9
23866018 - Ann Clin Microbiol Antimicrob. 2013 Jul 18;12:16
23093031 - J Antibiot (Tokyo). 2013 Jan;66(1):11-6
21396544 - Diagn Microbiol Infect Dis. 2011 Apr;69(4):449-53
21619555 - Bosn J Basic Med Sci. 2011 May;11(2):91-6
22886058 - Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):79-87
19002728 - Eur J Clin Microbiol Infect Dis. 2009 May;28(5):491-8
17913717 - J Antimicrob Chemother. 2007 Dec;60(6):1370-4
26675893 - J Clin Diagn Res. 2015 Nov;9(11):DC08-13
References_xml – ident: 1655_CR17
  doi: 10.1111/j.1469-0691.2008.02074.x
– volume: 6
  start-page: 232
  issue: 4
  year: 2006
  ident: 1655_CR29
  publication-title: Cameroon Afr Health Sci
– ident: 1655_CR39
  doi: 10.1128/AAC.00675-09
– volume: 5
  start-page: 58
  issue: 1
  year: 2013
  ident: 1655_CR10
  publication-title: Environ Microbiol Rep
  doi: 10.1111/1758-2229.12019
– volume: 42
  start-page: 925
  issue: 7
  year: 2006
  ident: 1655_CR28
  publication-title: Clin Infect Dis
  doi: 10.1086/500936
– volume: 65
  start-page: 490
  issue: 3
  year: 2010
  ident: 1655_CR9
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkp498
– ident: 1655_CR45
  doi: 10.1007/s10096-014-2141-8
– ident: 1655_CR43
  doi: 10.1128/JCM.43.7.3309-3313.2005
– volume: 69
  start-page: 449
  issue: 4
  year: 2011
  ident: 1655_CR34
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2010.11.011
– volume: 14
  start-page: 33
  issue: Suppl 1
  year: 2008
  ident: 1655_CR5
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2007.01867.x
– volume: 10
  start-page: 867
  issue: 4
  year: 1988
  ident: 1655_CR8
  publication-title: Rev Infect Dis
  doi: 10.1093/clinids/10.4.867
– volume: 12
  start-page: 155
  year: 2012
  ident: 1655_CR37
  publication-title: BMC Microbiol
  doi: 10.1186/1471-2180-12-155
– volume: 23
  start-page: 163
  issue: 3
  year: 2004
  ident: 1655_CR3
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-003-1084-2
– volume: 18
  start-page: 657
  issue: 4
  year: 2005
  ident: 1655_CR6
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.18.4.657-686.2005
– ident: 1655_CR30
  doi: 10.1007/s10096-008-0656-6
– ident: 1655_CR42
  doi: 10.3201/eid1402.070350
– volume: 8
  start-page: 1
  year: 2015
  ident: 1655_CR22
  publication-title: Infect Drug Resist
  doi: 10.2147/IDR.S74934
– ident: 1655_CR27
  doi: 10.1186/1471-2334-10-204
– ident: 1655_CR18
  doi: 10.1016/j.medmal.2015.08.003
– ident: 1655_CR19
  doi: 10.1080/21548331.2016.1133214
– ident: 1655_CR13
  doi: 10.2807/ese.13.47.19044-en
– volume: 16
  start-page: 163
  issue: 2
  year: 2010
  ident: 1655_CR40
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.2009.0108
– volume: 9
  start-page: 466
  issue: 5
  year: 2006
  ident: 1655_CR4
  publication-title: Curr Opin Microbiol
  doi: 10.1016/j.mib.2006.08.011
– ident: 1655_CR32
  doi: 10.1093/jac/dkm144
– volume: 11
  start-page: 91
  issue: 2
  year: 2011
  ident: 1655_CR24
  publication-title: Bosn J Basic Med Sci
  doi: 10.17305/bjbms.2011.2588
– volume: 12
  start-page: 16
  year: 2013
  ident: 1655_CR2
  publication-title: Ann Clin Microbiol Antimicrob
  doi: 10.1186/1476-0711-12-16
– volume: 14
  start-page: 104
  issue: Suppl 1
  year: 2008
  ident: 1655_CR25
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2007.01866.x
– volume: 6
  start-page: 2
  issue: Suppl 2
  year: 2000
  ident: 1655_CR1
  publication-title: Clin Microbiol Infect
  doi: 10.1046/j.1469-0691.2000.00002.x
– volume: 5
  start-page: 189
  issue: 3
  year: 1999
  ident: 1655_CR35
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.1999.5.189
– ident: 1655_CR44
  doi: 10.1093/jac/dkl199
– volume: 9
  start-page: DC08
  issue: 11
  year: 2015
  ident: 1655_CR20
  publication-title: J Clin Diagn Res
– volume: 68
  start-page: 75
  issue: 2
  year: 2015
  ident: 1655_CR31
  publication-title: Jpn J Antibiot
– ident: 1655_CR14
  doi: 10.3402/iee.v4.20342
– ident: 1655_CR11
  doi: 10.1093/jac/dkp194
– ident: 1655_CR23
  doi: 10.1038/ja.2012.91
– ident: 1655_CR33
  doi: 10.1093/jac/dkm381
– volume: 6
  start-page: 239
  year: 2015
  ident: 1655_CR36
  publication-title: China Front Microbiol
– volume: 89
  start-page: 960
  issue: 5
  year: 2013
  ident: 1655_CR7
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.12-0642
– volume: 81
  start-page: 1209
  issue: 6
  year: 2013
  ident: 1655_CR21
  publication-title: Urology
  doi: 10.1016/j.urology.2013.02.040
– volume: 33
  start-page: 326
  issue: 6
  year: 2005
  ident: 1655_CR16
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2005.03.009
– ident: 1655_CR15
  doi: 10.1186/2047-2994-1-23
– volume: 2
  start-page: 426
  issue: 6
  year: 2000
  ident: 1655_CR26
  publication-title: Isr Med Assoc J
– ident: 1655_CR12
  doi: 10.1111/j.1469-0691.2007.01850.x
– volume: 2015
  start-page: 846219
  year: 2015
  ident: 1655_CR46
  publication-title: Biomed Res Int
  doi: 10.1155/2015/846219
– volume: 27
  start-page: 545
  issue: 6
  year: 2006
  ident: 1655_CR38
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2006.01.007
– volume: 32
  start-page: 79
  issue: 1
  year: 2013
  ident: 1655_CR41
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-012-1717-4
– reference: 16061138 - Am J Infect Control. 2005 Aug;33(6):326-32
– reference: 22886058 - Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):79-87
– reference: 11523521 - Clin Microbiol Infect. 2000 Aug;6 Suppl 2:2-6
– reference: 22838634 - BMC Microbiol. 2012 Jul 28;12:155
– reference: 23866018 - Ann Clin Microbiol Antimicrob. 2013 Jul 18;12:16
– reference: 20071363 - J Antimicrob Chemother. 2010 Mar;65(3):490-5
– reference: 17604512 - Afr Health Sci. 2006 Dec;6(4):232-5
– reference: 26673518 - Hosp Pract (1995). 2016;44(1):33-40
– reference: 26433872 - Med Mal Infect. 2015 Sep;45(9):374-82
– reference: 16717055 - J Antimicrob Chemother. 2006 Jul;58(1):205-10
– reference: 24043693 - Am J Trop Med Hyg. 2013 Nov;89(5):960-4
– reference: 25692147 - Biomed Res Int. 2015;2015:846219
– reference: 21619555 - Bosn J Basic Med Sci. 2011 May;11(2):91-6
– reference: 19721071 - Antimicrob Agents Chemother. 2009 Nov;53(11):4957-8
– reference: 18828851 - Clin Microbiol Infect. 2008 Oct;14(10):895-907
– reference: 23093031 - J Antibiot (Tokyo). 2013 Jan;66(1):11-6
– reference: 24807441 - Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1719-23
– reference: 16713187 - Int J Antimicrob Agents. 2006 Jun;27(6):545-8
– reference: 24765249 - Infect Ecol Epidemiol. 2014 Mar 13;4:null
– reference: 18154526 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:33-41
– reference: 19002728 - Eur J Clin Microbiol Infect Dis. 2009 May;28(5):491-8
– reference: 26675893 - J Clin Diagn Res. 2015 Nov;9(11):DC08-13
– reference: 18154538 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53
– reference: 23601450 - Urology. 2013 Jun;81(6):1209-12
– reference: 19021958 - Euro Surveill. 2008 Nov 20;13(47):null
– reference: 18258110 - Emerg Infect Dis. 2008 Feb;14(2):195-200
– reference: 21396544 - Diagn Microbiol Infect Dis. 2011 Apr;69(4):449-53
– reference: 10566868 - Microb Drug Resist. 1999 Fall;5(3):189-93
– reference: 19474064 - J Antimicrob Chemother. 2009 Aug;64(2):274-7
– reference: 16511754 - Clin Infect Dis. 2006 Apr 1;42(7):925-34
– reference: 14986159 - Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):163-7
– reference: 16000453 - J Clin Microbiol. 2005 Jul;43(7):3309-13
– reference: 17496058 - J Antimicrob Chemother. 2007 Jul;60(1):140-4
– reference: 16942899 - Curr Opin Microbiol. 2006 Oct;9(5):466-75
– reference: 25870591 - Front Microbiol. 2015 Mar 27;6:239
– reference: 18154533 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:104-10
– reference: 26182812 - Jpn J Antibiot. 2015 Apr;68(2):75-84
– reference: 17913717 - J Antimicrob Chemother. 2007 Dec;60(6):1370-4
– reference: 23757131 - Environ Microbiol Rep. 2013 Feb;5(1):58-65
– reference: 16223952 - Clin Microbiol Rev. 2005 Oct;18(4):657-86
– reference: 20624313 - BMC Infect Dis. 2010 Jul 12;10:204
– reference: 3263690 - Rev Infect Dis. 1988 Jul-Aug;10(4):867-78
– reference: 10897231 - Isr Med Assoc J. 2000 Jun;2(6):426-9
– reference: 22958481 - Antimicrob Resist Infect Control. 2012 Jun 06;1(1):23
– reference: 20438347 - Microb Drug Resist. 2010 Jun;16(2):163-70
– reference: 25670909 - Infect Drug Resist. 2015 Jan 23;8:1-5
SSID ssj0017829
Score 2.4082928
Snippet Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The...
Background Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina...
BACKGROUND:Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina...
SourceID pubmedcentral
hal
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 326
SubjectTerms Adolescent
Adult
Aged
Anti-Bacterial Agents - pharmacology
beta-Lactamases - analysis
beta-Lactamases - classification
beta-Lactamases - genetics
Burkina Faso - epidemiology
Child
Child, Preschool
DNA, Bacterial - analysis
DNA, Bacterial - isolation & purification
DNA, Bacterial - metabolism
Enterobacteriaceae - drug effects
Enterobacteriaceae - enzymology
Enterobacteriaceae - isolation & purification
Enterobacteriaceae Infections - epidemiology
Enterobacteriaceae Infections - microbiology
Enterobacteriaceae Infections - pathology
Escherichia coli - drug effects
Escherichia coli - enzymology
Escherichia coli - isolation & purification
Female
Human health and pathology
Humans
Infant
Infant, Newborn
Infectious diseases
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - enzymology
Klebsiella pneumoniae - isolation & purification
Life Sciences
Male
Middle Aged
Odds Ratio
Phylogeny
Prevalence
Sequence Analysis, DNA
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZokRAXRHl1oUUGcUKyGjt-5YRK1dUKUU5U2lvkR6Ku1CbLbrd_hx_DH2PG6wQWpF5jJ3Ey43n7G0I-VFE7baJipZOKSRMr5r2SDCwTLgpvhEiHwi6-6dml_DJX8xxwW-eyykEmJkEd-4Ax8hOOwOgKzHvzafmDYdcozK7mFhp75CFCl2FJl5mPDhcH7VflTCa3-mQNsthgdZBmXCtY3o4u2rvCSsj_zcx_qyX_Uj_Tp-RJthvp6ZbQB-RB0z0jjy5yZvw5ucOCDbpcIXo3blbat3QIcLN0nHK1uaG_frJrF27dDeguukxgr6C6KOJyrmBjJ-BmFxrX0NSEiA7nJukCWBStUrro6OcNxtcdnbp1_4JcTs-_n81Y7qnAAooSpriLVSO8iT60VVOIoHxpEVfMmSBjFF5F1UZfuYDAO1EHr12UujWitUU05Uuy3_Vdc0ioCqBgCx9ty9GptN5KK0W0IrSuLbWckGL4u3XIgOPY9-K6To6H1fWWIDUWmSFB6nJCPo63LLdoG_dNfg8kG-chTvbs9GuN1wqOjpoRd3xCjgaK1nl3rus_vDQh78Zh2FeYLHFd02_SnNJUIK3gEa-2DDC-Cjx5dAXhC80Oa-ysZXekW1wl7G5ZlcCn5vX9y3pDHgtkUwTw5EdkH1ikOQbj59a_TRz-G-xzBbY
  priority: 102
  providerName: ProQuest
Title High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso
URI https://www.ncbi.nlm.nih.gov/pubmed/27400864
https://www.proquest.com/docview/1807858717
https://www.proquest.com/docview/1803797941
https://hal.science/hal-01862672
https://pubmed.ncbi.nlm.nih.gov/PMC4939587
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELaaVkJcEO8GSmQQJyTDrtevPSDUVI0iRCpUESnisvJjV42UbkLSVPBr-DH8MWac3UCg4sBlD2t7vfLMeGY8428IeZkHZZUOkmVWSCZ0yJlzUjCwTFKeOM15vBQ2OlPDsXg_kZM90pa3ahZwdaNrh_WkxsvZ669fvr0DgX8bBd6oNyvYYzVm_SiWKgnTdsgBKCaNcjoSv4IKoAzzJrB54zAEBtYCjXyxo6U6F5gj-bcB-mce5W-KaXCX3GksSnq8YYF7ZK-s75NboyZm_oBcYyoHXSwR1xvFmM4r2h59s3jRcrm-pD--s5n1V_YStBpdRBhYUGoUETuXIPIR0tn60pY0liei7Y1KOgXmRXuVTmvaX-PJu6UDu5o_JOPB6aeTIWuqLTCPmwyTqQ15yZ0Ozld5mXAvXWYQccxqL0LgTgZZBZdbj5A8QXmnbBCq0rwySdDZI7Jfz-vykFDpQfUmLpgqRXfTOCOM4MFwX9kqU6JLknZ1C99AkWNFjFkRXRKjig1tCkw_Q9oUWZe82g5ZbHA4_tX5BZBs2w8RtIfHHwp8l6Towml-nXbJUUvRomW7IkX4fQlOpO6S59tmkDgMo9i6nK9jn0znsI_BJx5vGGA7Vcs_XaJ3WGPnX3Zb6ulFRPUWeZbDzE_-e-RTcpsjMyPqZ3pE9oF7ymdgMV25HunoiYanOUl75KB_evbxvBdPH3pRQuB53v_8E4AnG1E
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLbaIgGXip0pBQyCC5LVxPGSHBAqy2hKZ3pqpbkFL4k6UpsMM50ifg3_gD_BH-M9Z4EBqbdeY8dO_Hb7-XuEvMq8Mkp7yRIjJBPaZ8xaKRh4JjGPrOY8XAqbHKnRifg8ldMN8rO7C4NplZ1ODIra1w73yPdiBEaX4N7rd_OvDKtG4elqV0KjYYvD4vs3CNmWbw8-An1fcz78dPxhxNqqAsyhMDEZG58V3GpvXZkVEXfSJikiaxnthPfcSi9LbzPjEHrGK2eV8UKVmpdp5HUC426SG2B4I5QoPe0DvBisbdaenMap2luC7teYjaRYrCQsx5rt2zzFzMv_3dp_szP_MnfDO2S79VPpfsNYd8lGUd0jNyftSfx9cokJInS-QLRwVA60Lmm3oc7C9c3F6pz--sHOjLsw52Ar6TyAy4KppIgDugBFEoCijStMQUPRI9rd06QzEAn0gumsou9XuJ9v6NAs6wfk5FpW-yHZquqqeEyodGDQI-vTMsYgNrWpSAX3KXelKRMlBiTqVjd3LcA51tk4y0Ogk6q8IUiOSW1IkDwZkDf9K_MG3eOqzi-BZH0_xOUe7Y9zfBbFGBhqfhkPyG5H0bzVBsv8D-8OyIu-GeQYD2dMVdSr0CfRGWhHGOJRwwD9VFwLDD3hD_Uaa6x9y3pLNTsNWOEiSzKYeefqz3pObo2OJ-N8fHB0-ITc5siyCB4a75ItYJfiKTheF_ZZ4HZKvly3eP0Gvy1EAQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+prevalence+of+extended-spectrum+%C3%9F-lactamase+producing+enterobacteriaceae+among+clinical+isolates+in+Burkina+Faso&rft.jtitle=BMC+infectious+diseases&rft.au=Ouedraogo%2C+Abdoul-Salam&rft.au=Sanou%2C+Mahamadou&rft.au=Kissou%2C+Aim%C3%A9e&rft.au=Sanou%2C+Soufiane&rft.date=2016-07-11&rft.pub=BioMed+Central&rft.eissn=1471-2334&rft.volume=16&rft_id=info:doi/10.1186%2Fs12879-016-1655-3&rft_id=info%3Apmid%2F27400864&rft.externalDocID=PMC4939587
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon